DeutschNewstral
Article
bizjournals.com on 2016-02-10 15:37
FDA lifts clinical hold; Heat's bladder cancer trial moves ahead
Related news
- FDA lifts suspension of Juno clinical trialbizjournals.com
- FDA lifts clinical hold on AstraZeneca cancer drug studiesbizjournals.com
- MMacroGenics stock gains 4% after FDA lifts partial clinical holdmarketwatch.com
- MGilead says FDA lifts partial clinical hold on MDS and AML magrolimab studies1 min readmarketwatch.com
- MSarepta stock rises after FDA lifts clinical hold on gene therapy programmarketwatch.com
- FDA lifts clinical hold on Peninsula company's off-the-shelf cancer cell therapy trialbizjournals.com
- FDA lifts clinical hold on Ocugen's Covid-19 vaccine study; stock skyrocketsbizjournals.com
- FDA lifts hold on Cel-Sci's clinical trial for head and neck cancer drugbizjournals.com
- Ocugen to resume Covaxin trials 'immediately' after FDA lifts its latest clinical holdbizjournals.com
FDA OKs drugs for bladder, blood cancersThe Salt Lake Tribune
FDA OKs new drug for bladder cancerabqjournal.com
Spectrum Pharma says U.S. FDA rejects its bladder cancer drugmetro.us
FDA grants approval for Astellas, Seattle Genetics' bladder cancer drugThe Jerusalem Post (JPost.com)
FDA OKs immune-boosting drug to treat advanced bladder cancerpressherald.com
FDA approves bladder cancer treatment by Culver City companyLA Times- FDA clears ALung device for clinical trialsbizjournals.com
FDA approves new Baxter clinical nutrition injectionsdailyherald.com
Updated FDA COVID-19 Guidance for Conduct of Clinical Trialsjdsupra.com- FDA Issues Long-Awaited Final Clinical Decision Support Software Guidancejdsupra.com
- FDA Finalizes Quality Recommendations for Cannabis in Clinical Investigationsjdsupra.com